M 
Medtronic MDT · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500
102.79
+0.97%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$36.36bn
FY2017FY2026
Net income
$4.80bn
FY2017FY2026
Free cash flow
$5.43bn
FY2017FY2026
Shareholders' equity
$49.46bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $36.36bn | $33.54bn | $32.36bn | $31.23bn | $31.69bn | $30.12bn | $28.91bn | $30.56bn | $29.95bn | $29.71bn |
| Gross profit | $23.64bn | $21.91bn | $21.15bn | $20.51bn | $21.54bn | $19.63bn | $19.49bn | $21.40bn | $20.89bn | $20.42bn |
| Research and development | $2.87bn | $2.73bn | $2.73bn | $2.70bn | $2.75bn | $2.49bn | $2.33bn | $2.33bn | $2.26bn | $2.19bn |
| Operating income | $6.47bn | $5.96bn | $5.14bn | $5.49bn | $5.75bn | $4.48bn | $4.79bn | $6.27bn | $6.64bn | $5.38bn |
| Net income | $4.80bn | $4.66bn | $3.68bn | $3.76bn | $5.04bn | $3.61bn | $4.79bn | $4.63bn | $3.10bn | $4.03bn |
| Diluted earnings per share | 3.74 | 3.62 | 2.86 | 2.82 | 3.78 | 2.66 | 3.54 | 3.43 | 2.28 | 2.95 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $93.03bn | $91.68bn | $89.98bn | $90.95bn | $90.98bn | $93.08bn | $90.69bn | $89.69bn | $91.39bn | $99.82bn |
| Cash and short-term investments | $9.22bn | $8.96bn | $8.01bn | $7.96bn | $10.57bn | $10.82bn | $10.95bn | $9.85bn | $11.23bn | $13.71bn |
| Total liabilities | $42.96bn | $43.42bn | $39.56bn | $39.28bn | $38.26bn | $41.48bn | $39.82bn | $39.48bn | $40.57bn | $49.40bn |
| Debt | $27.91bn | $28.52bn | $25.02bn | $24.36bn | $24.11bn | $26.39bn | $24.80bn | $25.32bn | $25.76bn | $33.45bn |
| Shareholders' equity | $49.46bn | $48.02bn | $50.21bn | $51.48bn | $52.55bn | $51.43bn | $50.74bn | $50.09bn | $50.72bn | $50.29bn |
| Shares outstanding | 1,285m | 1,288m | 1,287m | 1,332m | 1,332m | 1,355m | 1,352m | 1,351m | 1,361m | 1,366m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $7.33bn | $7.04bn | $6.79bn | $6.04bn | $7.35bn | $6.24bn | $7.23bn | $7.01bn | $4.68bn | $6.88bn |
| Capital spending | −$1.90bn | −$1.86bn | −$1.59bn | −$1.46bn | −$1.37bn | −$1.35bn | −$1.21bn | −$1.13bn | −$1.07bn | −$1.25bn |
| Free cash flow | $5.43bn | $5.18bn | $5.20bn | $4.58bn | $5.98bn | $4.88bn | $6.02bn | $5.87bn | $3.62bn | $5.63bn |
| Dividends paid | −$3.64bn | −$3.59bn | −$3.67bn | −$3.62bn | −$3.38bn | −$3.12bn | −$2.89bn | −$2.69bn | −$2.49bn | −$2.38bn |
Latest quarters
By quarter end
| Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.76bn | $9.81bn | $9.02bn | $8.96bn | $8.58bn | $8.93bn | $8.29bn | $8.40bn |
| Gross profit | $6.34bn | $7.44bn | $5.84bn | $5.90bn | $5.59bn | $5.78bn | $5.52bn | $5.47bn |
| Operating income | $1.95bn | $2.01bn | $1.70bn | $1.70bn | $1.54bn | $1.80bn | $1.72bn | $1.64bn |
| Net income | $1.47bn | $1.24bn | $1.14bn | $1.37bn | $1.04bn | $1.06bn | $1.29bn | $1.27bn |
| Diluted earnings per share | 1.14 | 0.97 | 0.89 | 1.07 | 0.81 | 0.82 | 1.01 | 0.99 |
| Cash from operations | $1.79bn | $2.57bn | $2.74bn | $925.0m | $1.09bn | $2.53bn | $2.57bn | $958.0m |
| Capital spending | −$503.0m | −$488.0m | −$444.0m | −$468.0m | −$504.0m | −$459.0m | −$476.0m | −$404.0m |
| Free cash flow | $1.29bn | $2.08bn | $2.30bn | $457.0m | $584.0m | $2.07bn | $2.10bn | $554.0m |
| Total assets | $93.31bn | $93.03bn | $91.48bn | $91.35bn | $90.97bn | $91.68bn | $89.97bn | $90.04bn |
| Cash and short-term investments | $8.82bn | $9.22bn | $8.38bn | $8.33bn | $8.12bn | $8.96bn | $7.92bn | $7.99bn |
| Debt | $28.10bn | $27.91bn | $28.07bn | $29.10bn | $28.61bn | $28.52bn | $26.61bn | $28.33bn |
| Shareholders' equity | $50.23bn | $49.46bn | $48.98bn | $48.65bn | $47.89bn | $48.02bn | $49.39bn | $48.49bn |
Financial ratios
Data as of 8 Sept 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 65.0% | 65.3% | 65.3% | 65.7% | 68.0% | 65.2% |
| Operating margin | 17.8% | 17.8% | 15.9% | 17.6% | 18.2% | 14.9% |
| Net margin | 13.2% | 13.9% | 11.4% | 12.0% | 15.9% | 12.0% |
| Return on equity | 9.7% | 9.7% | 7.3% | 7.3% | 9.6% | 7.0% |
| Return on assets | 5.2% | 5.1% | 4.1% | 4.1% | 5.5% | 3.9% |
| Free cash flow yield | 7.6% | 7.3% | 6.9% | 6.0% | 6.9% | 6.0% |
| Revenue growth | 8.4% | 3.6% | 3.6% | -1.4% | 5.2% | 4.2% |
| Earnings growth | 3.0% | 26.8% | -2.2% | -25.4% | 39.7% | -24.7% |
| Current ratio | 2.13x | 1.85x | 2.03x | 2.39x | 1.86x | 2.65x |
| Debt to equity | 0.56x | 0.59x | 0.50x | 0.47x | 0.46x | 0.51x |
| Equity ratio | 53.2% | 52.4% | 55.8% | 56.6% | 57.8% | 55.2% |
| Interest coverage | 9.04x | 8.17x | 7.15x | 8.62x | 10.40x | 4.85x |
| R&D as a share of sales | 7.9% | 8.1% | 8.5% | 8.6% | 8.7% | 8.3% |
| Buybacks as a share of market value | 0.2% | -0.0% | 3.4% | 0.0% | 1.7% | -0.2% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 5.2% | 3.8% | 2.3% |
| Operating income | 5.6% | 7.6% | 1.9% |
| Net income | 8.5% | 5.9% | 3.1% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 65.2% | 65.3% | 65.7% | 67.1% |
| Operating margin | 17.8% | 17.3% | 17.0% | 18.0% |
| Net margin | 13.5% | 12.7% | 13.1% | 13.3% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 28.1 | 26.5 | 28.0 | 29.2 | 20.5 | 38.9 | 33.1 | 33.1 | 39.9 | 27.4 |
| Price to sales | 3.7 | 3.7 | 3.2 | 3.5 | 3.3 | 4.7 | 5.5 | 5.0 | 4.1 | 3.7 |
Market value over time
31 Oct 2016 to 4 Sept 2026, in USD
$114.21bn$121.02bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 23% | -2% | 6% | -23% | -13% | 1% | 27% | 10% | 12% | -4% |
Dividends and splits
Per share, in the currency the company pays
Paid for 36 years. Last went ex-dividend on 25 Sept 2026.
| FY2027 | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 1.44 | 2.84 | 2.80 | 2.76 | 2.72 | 2.52 | 2.32 | 2.16 |
- 2-for-1 split · 27 Sept 1999
- 2-for-1 split · 15 Sept 1997
- 2-for-1 split · 29 Sept 1995
- 2-for-1 split · 30 Sept 1994
- 2-for-1 split · 30 Aug 1991
- 2-for-1 split · 31 Aug 1989
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.